Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)
1
x
$
0.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
View Cart
Checkout
Home
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
“Quetiapine XR Negative Clinical Trials Report by Gang Wang” has been added to your cart.
View cart
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
$
30.00
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 1 Articles
Tags:
antidepressants
,
antipsychotics
,
mark-beale
,
medworks-media
,
obesity
,
psychopharmacology-bulletin
,
thomas-l-schwartz
,
weight-management
Description
Description
Thomas L. Schwartz, MD
CASE HISTORIES
Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
Thomas L. Schwartz, MD, and Mark Beale, MD
Related products
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Zonisamide for Bipolar Depression by Deborah Dauphinais
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Page load link
Go to Top
